Patients with either increased tau or neurogenerative diseases and no evidence of Aβ deposition are considered A−/TN + who are recently defined as suspected non-Alzheimer’s pathology (SNAP) and reflect a non-AD related neurodegeneration [42, 43]. The gene discussed is MAPT; the disease is Alzheimer disease.